Nucana Plc Adr (NCNA)

Mar 12, 2025

Stock Update - Investorsobserver

Mar 12, 2025

Nov 25, 2024

NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan

Nov 25, 2024

Sep 27, 2024

Get in on NuCana plc ADR’s (NCNA) buy-in window today! - SETE News

Sep 27, 2024

Sep 26, 2024

NuCana plc ADR Inc. (NCNA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Sep 26, 2024

Sep 26, 2024

NuCana secures new US patent for cancer treatment NUC-7738 - Investing.com India

Sep 26, 2024

Sep 26, 2024

Market Watch: NuCana plc ADR (NCNA)’s Noteworthy Drop, Closing at 3.05 - The Dwinnex

Sep 26, 2024

Sep 19, 2024

Daily Market Movement: NuCana plc ADR (NCNA) Sees a -7.03 Decrease, Closing at 3.44 - The Dwinnex

Sep 19, 2024

Sep 17, 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance

Sep 17, 2024

Sep 16, 2024

NCNA’s Financial Health: Exploring NuCana plc ADR’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Sep 16, 2024

Sep 03, 2024

NuCana price target lowered to $25 from $150 at Oppenheimer - TipRanks

Sep 03, 2024

Sep 03, 2024

Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials - Investing.com

Sep 03, 2024

Aug 29, 2024

NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks

Aug 29, 2024

Jul 22, 2024

NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com

Jul 22, 2024

Mar 27, 2024

NuCana plc Announces Reverse ADS Split - TipRanks

Mar 27, 2024

Jan 03, 2024

NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha

Jan 03, 2024

Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021

Jun 01, 2020

Will NuCana Continue to Surge Higher? - Nasdaq

Jun 01, 2020

Oct 23, 2017

NuCana (NCNA) Stock Price, News & Analysis - MarketBeat

Oct 23, 2017